Reversal of hepatorenal syndrome in four patients by peroral misoprostol (prostaglandin E1 analogue) and albumin administration
- 1 September 1990
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 11 (2) , 153-158
- https://doi.org/10.1016/0168-8278(90)90106-2
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Pathogenesis of Sodium and Water Retention in High-Output and Low-Output Cardiac Failure, Nephrotic Syndrome, Cirrhosis, and PregnancyNew England Journal of Medicine, 1988
- Pathogenesis of Sodium and Water Retention in High-Output and Low-Output Cardiac Failure, Nephrotic Syndrome, Cirrhosis, and PregnancyNew England Journal of Medicine, 1988
- Prerenal Failure: A Deleterious Shift from Renal Compensation to DecompensationNew England Journal of Medicine, 1988
- Pathophysiology of ascites and functional renal failure in cirrhosisJournal of Hepatology, 1988
- Renal eicosanoids as determinants of renal function in liver diseaseHepatology, 1987
- 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.Journal of Clinical Investigation, 1987
- Urinary excretion of 6-keto-prostaglandin F1α, thromboxane B2 and prostaglandin E2 in cirrhosis with ascitesJournal of Hepatology, 1986
- Sympathetic nervous activity in cirrhosisJournal of Hepatology, 1985
- Sympathetic nervous activity, renin‐angiotensin system and renal excretion of prostaglandin E2 in cirrhosis. Relationship to functional renal failure and sodium and water excretionEuropean Journal of Clinical Investigation, 1983
- Potential Role of Increased Sympathetic Activity in Impaired Sodium and Water Excretion in CirrhosisNew England Journal of Medicine, 1982